First Time Loading...

Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 255.87 USD 1.28% Market Closed
Updated: Mar 2, 2024

Intrinsic Value

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. [ Read More ]

The intrinsic value of one DHR stock under the Base Case scenario is 185.17 USD. Compared to the current market price of 255.87 USD, Danaher Corp is Overvalued by 28%.

Key Points:
DHR Intrinsic Value
Base Case
185.17 USD
Overvaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Danaher Corp

Backtest DHR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DHR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Danaher 2023: Transitional Headwinds Amid Growth
2023-Q4 Earnings Call

Danaher 2023: Transitional Headwinds Amid Growth

In 2023, Danaher navigated market challenges, delivering $23.9 billion in sales with a core revenue decline of 10%, offset by innovations across its businesses. Amidst COVID-19 headwinds, the firm demonstrated resilience with a high free cash flow to net income conversion ratio above 120%. The coming year is expected to remain transitional through H1, but optimistically aiming for a high single-digit core growth rate by year-end.

Financials

Balance Sheet Decomposition
Danaher Corp

Current Assets 13.9B
Cash & Short-Term Investments 5.9B
Receivables 4B
Other Current Assets 4.1B
Non-Current Assets 70.6B
PP&E 5.6B
Intangibles 62.4B
Other Non-Current Assets 2.6B
Current Liabilities 8.3B
Accounts Payable 1.8B
Accrued Liabilities 3.3B
Other Current Liabilities 3.2B
Non-Current Liabilities 22.7B
Long-Term Debt 16.7B
Other Non-Current Liabilities 6B
Efficiency
Fundamental Scores

DHR Profitability Score
Profitability Due Diligence

Danaher Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
Positive Net Income
60/100
Profitability
Score

Danaher Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

DHR Solvency Score
Solvency Due Diligence

Danaher Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
High Interest Coverage
69/100
Solvency
Score

Danaher Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DHR Price Targets Summary
Danaher Corp

Wall Street analysts forecast DHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHR is 265.91 USD with a low forecast of 212.1 USD and a high forecast of 304.5 USD.

Lowest
Price Target
212.1 USD
17% Downside
Average
Price Target
265.91 USD
4% Upside
Highest
Price Target
304.5 USD
19% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DHR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DHR Price
Danaher Corp

1M 1M
+4%
6M 6M
-2%
1Y 1Y
+3%
3Y 3Y
+15%
5Y 5Y
+107%
10Y 10Y
+368%
Annual Price Range
255.87
52w Low
185.1
52w High
265.59
Price Metrics
Average Annual Return 23.4%
Standard Deviation of Annual Returns 28.23%
Max Drawdown -44%
Shares Statistics
Market Capitalization 189.1B USD
Shares Outstanding 739 702 016
Percentage of Shares Shorted 0.93%

DHR Return Decomposition
Main factors of price return

What is price return decomposition?

DHR News

Other Videos

Last Important Events
Danaher Corp

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Danaher Corp

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Danaher Corp Logo
Danaher Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

189.1B USD

Dividend Yield

0.43%

Description

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 78,000 full-time employees. The firm operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Contact

WASHINGTON DC
WASHINGTON
2200 Pennsylvania Ave NW Ste 800W
+12028280850.0
https://www.danaher.com/

IPO

1969-12-10

Employees

78 000

Officers

Co-Founder & Chairman
Mr. Steven M. Rales
President, CEO & Director
Mr. Rainer M. Blair
Co-Founder & Director
Mr. Mitchell P. Rales
CFO & Executive VP
Mr. Matthew R. McGrew
Senior VP & Chief Science Officer
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.
Executive Vice President
Mr. Joakim Weidemanis
Show More
VP & Chief Accounting Officer
Mr. Christopher M. Bouda
Vice President of Investor Relations
Mr. John Bedford
Senior VP, General Counsel & Chief Compliance Officer
Mr. Brian W. Ellis
Senior Vice President of Corporate Development
Mr. Daniel A. Raskas J.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one DHR stock?

The intrinsic value of one DHR stock under the Base Case scenario is 185.17 USD.

Is DHR stock undervalued or overvalued?

Compared to the current market price of 255.87 USD, Danaher Corp is Overvalued by 28%.